Home
Scholarly Works
A phase III study of Æ-941 with induction...
Journal article

A phase III study of Æ-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell Lung cancer (NSCLC) (NCI T99–0046, RTOG 02–70, MDA 99–303): An interim report of toxicity and response

Authors

Lu C; Komaki R; Herbst RS; Evans WK; Lee JJ; Truong M; Moore CA; Choy H; Bleyer A; Fisch MJ

Journal

Journal of Clinical Oncology, Vol. 23, No. 16_suppl, pp. 7144–7144

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

June 1, 2005

DOI

10.1200/jco.2005.23.16_suppl.7144

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team